Name: Global Anti-Malarial Drug Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.8 (145 reviews)

Global Anti-Malarial Drug Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Global Anti-Malarial Drug Market report clarifies the latest as well as historical market trends, share, revenue, volume, or size for the better understanding of the economic and growth aspects. The report is a complete representation of the market statistics and concepts regarding market growth enhancement. The geographical analysis and competitive landscape are the segments majorly important in providing a complete Anti-Malarial Drug market overview. Additionally, the market achievements and threats mentioned in the report can help the investors and readers in their decision making. In this report, the future market status in terms of financial and developmental growth shed more light on the Anti-Malarial Drug market status during the forecast period.

Data provided by Extent Research. Source: https://www.extentresearch.com/anti-malarial-drug-market

Major Key Market Players: GlaxoSmithKline, Ranbaxy, Zydus Cadila, Alvizia, Bayer, Ipca, Merck, F. Hoffmann-La Roche, Novartis, Pfizer, .

The company profiling provides wide-ranging data that primarily targets the latest product launches, new manufacturing processes, supply & demand ratio, and financial profits. The key business tactics adopted by the dominating players is also reported in the Global Anti-Malarial Drug Market study.

Segmentation of the Global Anti-Malarial Drug Market:

By Product type

Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale,

by Application

Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others,

Regional Analysis:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

The geographical analysis focuses on factors such as the regional market attractiveness, consumer preferences, economic status, product demand, and environmental conditions adhering to the market development.

In conclusion, the Global Anti-Malarial Drug Market report illuminates data such as the market growth drivers, industrial analysis, competitive landscape, regional analysis, and changing market dynamics.

Extrapolates Covered In The Global Anti-Malarial Drug Market Report:

Study over changing competitive market dynamics
Latest opportunities & challenges, threats, historical & future trends
Analysis of the geographical distribution and competitive landscape for better
Report also covers key drivers, latest development trends, new product launches, and other vital aspects as well.
Statistical study covering market size, share, and revenue for the better understanding of the current market status.

Report Provides Answers To The Following Questions:

What are the key market drivers anticipated to propel market growth?
Which is the key factor expected fuel Global Anti-Malarial Drug Market growth rate?
Which are the key business strategies adopted by key market players?
Which are the regions exhibiting rapid market growth?

Report Scope and Market Segmentation

ATTRIBUTES	Global Anti-Malarial Drug Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Anti-Malarial Drug Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Anti-Malarial Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Anti-Malarial Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Plasmodium Falciparum
        1.2.3 Plasmodium Vivax
        1.2.4 Plasmodium Malariae
        1.2.5 Plasmodium Ovale
    1.3 Market by Application
        1.3.1 Global Anti-Malarial Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 E-Commerce
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Anti-Malarial Drug Sales Estimates and Forecasts 2017-2035
    2.2 Global Anti-Malarial Drug Revenue Estimates and Forecasts 2017-2035
    2.3 Global Anti-Malarial Drug Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Anti-Malarial Drug Sales by Region
        2.4.1 Global Anti-Malarial Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Anti-Malarial Drug by Region (2023-2035)
    2.5 Global Anti-Malarial Drug Revenue by Region
        2.5.1 Global Anti-Malarial Drug Revenue by Region (2017-2022)
        2.5.2 Global Anti-Malarial Drug Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Anti-Malarial Drug Sales by Manufacturers
        3.1.1 Global Top Anti-Malarial Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Malarial Drug in 2021
    3.2 Global Anti-Malarial Drug Revenue by Manufacturers
        3.2.1 Global Anti-Malarial Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Anti-Malarial Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Revenue in 2021
    3.3 Global Anti-Malarial Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Anti-Malarial Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Anti-Malarial Drug Sales by Type
        4.1.1 Global Anti-Malarial Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Anti-Malarial Drug Forecasted Sales by Type (2023-2035)
        4.1.3 Global Anti-Malarial Drug Sales Market Share by Type (2017-2035)
    4.2 Global Anti-Malarial Drug Revenue by Type
        4.2.1 Global Anti-Malarial Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Anti-Malarial Drug Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Anti-Malarial Drug Revenue Market Share by Type (2017-2035)
    4.3 Global Anti-Malarial Drug Price by Type
        4.3.1 Global Anti-Malarial Drug Price by Type (2017-2022)
        4.3.2 Global Anti-Malarial Drug Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Anti-Malarial Drug Sales by Application
        5.1.1 Global Anti-Malarial Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Anti-Malarial Drug Forecasted Sales by Application (2023-2035)
        5.1.3 Global Anti-Malarial Drug Sales Market Share by Application (2017-2035)
    5.2 Global Anti-Malarial Drug Revenue by Application
        5.2.1 Global Anti-Malarial Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Anti-Malarial Drug Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Anti-Malarial Drug Revenue Market Share by Application (2017-2035)
    5.3 Global Anti-Malarial Drug Price by Application
        5.3.1 Global Anti-Malarial Drug Price by Application (2017-2022)
        5.3.2 Global Anti-Malarial Drug Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Anti-Malarial Drug Market Size by Type
        6.1.1 North America Anti-Malarial Drug Sales by Type (2017-2035)
        6.1.2 North America Anti-Malarial Drug Revenue by Type (2017-2035)
    6.2 North America Anti-Malarial Drug Market Size by Application
        6.2.1 North America Anti-Malarial Drug Sales by Application (2017-2035)
        6.2.2 North America Anti-Malarial Drug Revenue by Application (2017-2035)
    6.3 North America Anti-Malarial Drug Market Size by Country
        6.3.1 North America Anti-Malarial Drug Sales by Country (2017-2035)
        6.3.2 North America Anti-Malarial Drug Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Anti-Malarial Drug Market Size by Type
        7.1.1 Europe Anti-Malarial Drug Sales by Type (2017-2035)
        7.1.2 Europe Anti-Malarial Drug Revenue by Type (2017-2035)
    7.2 Europe Anti-Malarial Drug Market Size by Application
        7.2.1 Europe Anti-Malarial Drug Sales by Application (2017-2035)
        7.2.2 Europe Anti-Malarial Drug Revenue by Application (2017-2035)
    7.3 Europe Anti-Malarial Drug Market Size by Country
        7.3.1 Europe Anti-Malarial Drug Sales by Country (2017-2035)
        7.3.2 Europe Anti-Malarial Drug Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Anti-Malarial Drug Market Size by Type
        8.1.1 Asia Pacific Anti-Malarial Drug Sales by Type (2017-2035)
        8.1.2 Asia Pacific Anti-Malarial Drug Revenue by Type (2017-2035)
    8.2 Asia Pacific Anti-Malarial Drug Market Size by Application
        8.2.1 Asia Pacific Anti-Malarial Drug Sales by Application (2017-2035)
        8.2.2 Asia Pacific Anti-Malarial Drug Revenue by Application (2017-2035)
    8.3 Asia Pacific Anti-Malarial Drug Market Size by Region
        8.3.1 Asia Pacific Anti-Malarial Drug Sales by Region (2017-2035)
        8.3.2 Asia Pacific Anti-Malarial Drug Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Anti-Malarial Drug Market Size by Type
        9.1.1 Latin America Anti-Malarial Drug Sales by Type (2017-2035)
        9.1.2 Latin America Anti-Malarial Drug Revenue by Type (2017-2035)
    9.2 Latin America Anti-Malarial Drug Market Size by Application
        9.2.1 Latin America Anti-Malarial Drug Sales by Application (2017-2035)
        9.2.2 Latin America Anti-Malarial Drug Revenue by Application (2017-2035)
    9.3 Latin America Anti-Malarial Drug Market Size by Country
        9.3.1 Latin America Anti-Malarial Drug Sales by Country (2017-2035)
        9.3.2 Latin America Anti-Malarial Drug Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Anti-Malarial Drug Market Size by Type
        10.1.1 Middle East and Africa Anti-Malarial Drug Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Anti-Malarial Drug Revenue by Type (2017-2035)
    10.2 Middle East and Africa Anti-Malarial Drug Market Size by Application
        10.2.1 Middle East and Africa Anti-Malarial Drug Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Anti-Malarial Drug Revenue by Application (2017-2035)
    10.3 Middle East and Africa Anti-Malarial Drug Market Size by Country
        10.3.1 Middle East and Africa Anti-Malarial Drug Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Anti-Malarial Drug Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GlaxoSmithKline Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 Ranbaxy
        11.2.1 Ranbaxy Corporation Information
        11.2.2 Ranbaxy Overview
        11.2.3 Ranbaxy Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Ranbaxy Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Ranbaxy Recent Developments
    11.3 Zydus Cadila
        11.3.1 Zydus Cadila Corporation Information
        11.3.2 Zydus Cadila Overview
        11.3.3 Zydus Cadila Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Zydus Cadila Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Zydus Cadila Recent Developments
    11.4 Alvizia
        11.4.1 Alvizia Corporation Information
        11.4.2 Alvizia Overview
        11.4.3 Alvizia Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Alvizia Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Alvizia Recent Developments
    11.5 Bayer
        11.5.1 Bayer Corporation Information
        11.5.2 Bayer Overview
        11.5.3 Bayer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bayer Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bayer Recent Developments
    11.6 Ipca
        11.6.1 Ipca Corporation Information
        11.6.2 Ipca Overview
        11.6.3 Ipca Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Ipca Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Ipca Recent Developments
    11.7 Merck
        11.7.1 Merck Corporation Information
        11.7.2 Merck Overview
        11.7.3 Merck Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Merck Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck Recent Developments
    11.8 F. Hoffmann-La Roche
        11.8.1 F. Hoffmann-La Roche Corporation Information
        11.8.2 F. Hoffmann-La Roche Overview
        11.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 F. Hoffmann-La Roche Recent Developments
    11.9 Novartis
        11.9.1 Novartis Corporation Information
        11.9.2 Novartis Overview
        11.9.3 Novartis Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Novartis Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Novartis Recent Developments
    11.10 Pfizer
        11.10.1 Pfizer Corporation Information
        11.10.2 Pfizer Overview
        11.10.3 Pfizer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Pfizer Anti-Malarial Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Anti-Malarial Drug Industry Chain Analysis
    12.2 Anti-Malarial Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Anti-Malarial Drug Production Mode & Process
    12.4 Anti-Malarial Drug Sales and Marketing
        12.4.1 Anti-Malarial Drug Sales Channels
        12.4.2 Anti-Malarial Drug Distributors
    12.5 Anti-Malarial Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Anti-Malarial Drug Industry Trends
    13.2 Anti-Malarial Drug Market Drivers
    13.3 Anti-Malarial Drug Market Challenges
    13.4 Anti-Malarial Drug Market Restraints
14 Key Findings in The Global Anti-Malarial Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Anti-Malarial Drug Market